Advancing cancer immunotherapy research
- State-of the-art technology and systems for molecular and cellular analysis of immune response to cancer therapeutics
- Scientific advice and technical support
CIO-TIGL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network